Invention Grant
- Patent Title: Immune gene signatures in cancer
-
Application No.: US15171713Application Date: 2016-06-02
-
Publication No.: US10041129B2Publication Date: 2018-08-07
- Inventor: James J. Mulé , Domenico Coppola , Timothy J. Yeatman , Andrey Loboda , Michael V. Nebozhyn
- Applicant: H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Applicant Address: US FL Tampa
- Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Current Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Current Assignee Address: US FL Tampa
- Agency: Fish & Richardson P.C.
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G01N33/574 ; C12Q1/6886
Abstract:
This invention relates to methods for selecting a treatment, treating, and predicting survival time in subjects with cancer, such as colorectal cancer, based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes.
Public/Granted literature
- US20160326599A1 Immune Gene Signatures in Cancer Public/Granted day:2016-11-10
Information query
